Drug:
Reaction: BLOOD GLUCOSE INCREASED
20250101 - 20251231
No. 901 - 1000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 901 | 24969598 |
CN |
77 | 2 |
Anaemia, Platelet count decreased, Lymphocyte count decreased, Hypoalbuminaemia, Neutrophil count decreased, White blood cell count decreased, Alanine aminotransferase decreased, Blood glucose increased, Blood calcitonin, |
||||
POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, RITUXIMAB, OXALIPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, ETOPOSIDE, CISPLATIN, MESNA, MESNA INJECTION, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, |
||||
| 902 | 24969623 |
56 | 2 | |
Blood glucose increased, Diabetic ketoacidosis, |
||||
LETROZOLE, |
||||
| 903 | 24969664 |
US |
81 | 1 |
Hypoacusis, Blood glucose increased, Incorrect dose administered, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 904 | 24969665 |
US |
71 | 2 |
Dizziness, COVID-19, Blood glucose decreased, Blood glucose increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIMEPIRIDE, |
||||
| 905 | 24969993 |
US |
67 | |
Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 906 | 24970516 |
US |
61 | 1 |
Blood glucose increased, |
||||
INSULIN HUMAN, |
||||
| 907 | 24970532 |
US |
73 | 2 |
Fall, Patella fracture, Femur fracture, Illness, Weight decreased, Blood glucose increased, Gait disturbance, Decreased appetite, |
||||
DULAGLUTIDE, |
||||
| 908 | 24970586 |
US |
44 | 2 |
Diarrhoea, Blood glucose increased, Headache, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 909 | 24971082 |
US |
2 | |
Deafness unilateral, Blood glucose increased, Renal disorder, Peripheral swelling, Generalised oedema, Cardiac disorder, Oesophageal disorder, Vomiting, Nausea, |
||||
SEMAGLUTIDE, |
||||
| 910 | 24971158 |
US |
73 | |
Fall, Atrial fibrillation, Blood glucose increased, Wheelchair user, Cardiac perforation, Spinal fracture, Loss of consciousness, |
||||
DAPAGLIFLOZIN, |
||||
| 911 | 24971278 |
DE |
2 | |
Diabetic coma, Blood glucose increased, Expired product administered, |
||||
INSULIN GLULISINE, |
||||
| 912 | 24971899 |
US |
71 | 2 |
Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 913 | 24971946 |
US |
70 | 2 |
Blood glucose increased, Blood potassium decreased, |
||||
PALBOCICLIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ANASTROZOLE, ANASTROZOLE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EXEMESTANE, LISINOPRIL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SIMVASTATIN, |
||||
| 914 | 24972157 |
TR |
49 | 1 |
Coma, Blood glucose increased, Blood gases abnormal, Device defective, |
||||
INSULIN GLARGINE, |
||||
| 915 | 24963119 |
US |
53 | 1 |
Product dose omission issue, Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 916 | 24963152 |
AU |
||
Myocardial infarction, Blood glucose increased, Weight increased, |
||||
SEMAGLUTIDE, |
||||
| 917 | 24963276 |
US |
71 | 2 |
Myocardial infarction, Cataract, Blood pressure increased, Cardiac disorder, Blindness, Weight decreased, Weight increased, Peripheral swelling, Pain in extremity, Dysphonia, Dysstasia, Gait inability, Blood disorder, Injection site pain, Blood glucose fluctuation, Blood glucose increased, Product dose omission issue, |
||||
INSULIN ASPART, INSULIN ASPART, INSULIN ASPART, INSULIN ASPART, INSULIN ASPART, INSULIN GLARGINE, |
||||
| 918 | 24963389 |
US |
67 | 1 |
Blood glucose increased, Injection site bruising, Injection site haemorrhage, Injection site pain, |
||||
INSULIN LISPRO-AABC, INSULIN LISPRO, INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 919 | 24963782 |
US |
61 | 2 |
Blood glucose increased, Wrong technique in product usage process, |
||||
INSULIN HUMAN, INSULIN HUMAN, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 920 | 24963786 |
US |
50 | 1 |
Incorrect dose administered, Visual impairment, Blood glucose increased, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 921 | 24963961 |
US |
72 | 2 |
Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 922 | 24964100 |
CA |
56 | 2 |
Abdominal discomfort, Arthralgia, Back pain, Bladder pain, Blood glucose decreased, Blood glucose increased, Blood insulin decreased, Blood insulin increased, COVID-19 immunisation, Chills, Contusion, Diarrhoea, Cystitis, Dizziness, Ear pain, Erythema, Fall, Fatigue, Haematochezia, Headache, Hyperhidrosis, Hyperkeratosis follicularis et parafollicularis, Infusion site erythema, Infusion site haemorrhage, Infusion site pruritus, Infusion site warmth, Injection site reaction, Irritable bowel syndrome, Malaise, Muscle spasms, Myalgia, Nausea, Neck pain, Oral pain, Oropharyngeal pain, Pain, Pain in extremity, Pain in jaw, Peripheral swelling, Pruritus, Rash, Rhinorrhoea, Sciatica, Sinus congestion, Tenderness, Throat irritation, Tonsillitis, Toothache, Vertigo, Visual impairment, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, TRAMADOL HYDROCHLORIDE, CANDESARTAN CILEXETIL, ATENOLOL, TOLTERODINE TARTRATE, DEXLANSOPRAZOLE, EZETIMIBE, DIMENHYDRINATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN DEGLUDEC, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, |
||||
| 923 | 24964114 |
US |
89 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 924 | 24964121 |
US |
58 | 2 |
Blood glucose increased, Incorrect dose administered, Feeling cold, Injection site pain, Blood glucose decreased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 925 | 24964194 |
US |
81 | 2 |
Dental operation, Pulmonary embolism, Blood cholesterol increased, Device difficult to use, Accidental exposure to product, Product communication issue, Blood glucose increased, |
||||
EVOLOCUMAB, |
||||
| 926 | 24964536 |
PL |
30 | 2 |
Hepatotoxicity, Ill-defined disorder, Catheter site infection, Blood glucose decreased, Blood glucose increased, Thyroxine free increased, Product use in unapproved indication, |
||||
CARBOPLATIN, DOXORUBICIN HYDROCHLORIDE, PEMBROLIZUMAB, PACLITAXEL, |
||||
| 927 | 24965178 |
CA |
2 | |
Pancreatitis, Pancreatolithiasis, Blood glucose increased, |
||||
VEDOLIZUMAB, |
||||
| 928 | 24965822 |
US |
||
Blood glucose increased, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 929 | 24965851 |
US |
2 | |
Blood triglycerides increased, Blood glucose increased, Low density lipoprotein increased, |
||||
EVOLOCUMAB, |
||||
| 930 | 24966577 |
US |
77 | 1 |
Carpal tunnel syndrome, Blood glucose increased, Muscular weakness, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 931 | 24966578 |
US |
67 | 1 |
Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, |
||||
| 932 | 24966682 |
US |
70 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 933 | 24966757 |
US |
67 | 2 |
Blood glucose increased, |
||||
PALBOCICLIB, |
||||
| 934 | 24966965 |
PL |
71 | 1 |
Dyspnoea, Cough, Dermatitis allergic, Product dose omission issue, Pneumonia, Myoglobin blood increased, Blood glucose increased, C-reactive protein increased, Spinal osteoarthritis, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 935 | 24967022 |
US |
1 | |
Brain neoplasm, Cerebrovascular accident, Weight decreased, Glycosylated haemoglobin increased, Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 936 | 24967191 |
CN |
61 | 1 |
Lipids increased, Blood glucose increased, |
||||
| 937 | 24967258 |
US |
||
Kidney fibrosis, Arteriosclerosis coronary artery, Weight increased, Blood pressure decreased, Calcinosis, Fibrocystic breast disease, Breast calcifications, Coronary artery disease, Computerised tomogram kidney abnormal, Blood glucose increased, Blood urea increased, Blood creatinine increased, Blood calcium increased, Glomerular filtration rate decreased, Vitamin B6 decreased, |
||||
ASFOTASE ALFA, |
||||
| 938 | 24957884 |
US |
||
Insulin resistance, Blood glucose increased, |
||||
EVOLOCUMAB, |
||||
| 939 | 24958133 |
US |
76 | 2 |
Neuropathy peripheral, Blood glucose increased, Nausea, Decreased appetite, Weight decreased, Drug ineffective, |
||||
DULAGLUTIDE, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 940 | 24958200 |
US |
46 | 2 |
Dyspepsia, Flatulence, Eructation, Nausea, Faeces soft, Diarrhoea, Blood glucose increased, Glycosylated haemoglobin abnormal, |
||||
EMPAGLIFLOZIN, TIRZEPATIDE, EZETIMIBE, PREGABALIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SACUBITRIL AND VALSARTAN, SEMAGLUTIDE, SITAGLIPTIN, |
||||
| 941 | 24958448 |
CN |
68 | 2 |
Hyperpyrexia, Chills, Lymphoma, Breast mass, Sinusitis, Pulpitis dental, Thyroid disorder, Lymphoid tissue hyperplasia, Bronchiolitis, Granuloma, Inflammation, Arteriosclerosis, Pleural effusion, Hiatus hernia, Hepatic steatosis, Haemorrhoids, Nodule, Injection site granuloma, Spinal osteoarthritis, Enostosis, Alanine aminotransferase increased, Aspartate aminotransferase increased, Protein total decreased, Blood albumin decreased, Gamma-glutamyltransferase increased, Blood cholinesterase decreased, Blood uric acid increased, Beta 2 microglobulin increased, Blood chloride increased, Blood urea increased, Blood glucose increased, Carbon dioxide decreased, Blood lactate dehydrogenase increased, Blood creatine phosphokinase decreased, Alpha hydroxybutyrate dehydrogenase decreased, Serum amyloid A protein increased, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, Mean cell volume decreased, Mean cell haemoglobin decreased, Red cell distribution width increased, Platelet count decreased, Lymphocyte count decreased, Eosinophil count decreased, Lymphocyte percentage decreased, Neutrophil percentage decreased, Eosinophil percentage decreased, Plateletcrit decreased, |
||||
RITUXIMAB, POLATUZUMAB VEDOTIN, |
||||
| 942 | 24958680 |
US |
||
Cerebrovascular accident, Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, SEMAGLUTIDE, PANTOPRAZOLE, NITROGLYCERIN, MIRABEGRON, LOSARTAN, LEVOTHYROXINE, GLIPIZIDE, FUROSEMIDE, FINASTERIDE, EMPAGLIFLOZIN, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, ERGOCALCIFEROL, CARVEDILOL, CARBIDOPA AND LEVODOPA, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALLOPURINOL, |
||||
| 943 | 24958817 |
MX |
76 | 2 |
Carcinoembryonic antigen increased, Colon cancer, Urine ketone body present, Urobilinogen urine increased, White blood cells urine positive, Urinary sediment present, Urinary casts, Bacterial test positive, Haemoglobin increased, Monocyte count increased, Chromaturia, Blood creatinine decreased, Blood glucose increased, Haematuria, Blood alkaline phosphatase increased, Blood magnesium decreased, AST/ALT ratio abnormal, Bilirubin conjugated increased, Proteinuria, Mucosal inflammation, |
||||
FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, |
||||
| 944 | 24959012 |
US |
||
Aortic valve stenosis, Fatigue, Blood glucose increased, Musculoskeletal pain, Arthritis, Loss of libido, Weight increased, Haemoglobin decreased, |
||||
RELUGOLIX, RELUGOLIX, GABAPENTIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GUAIFENESIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, LEVOTHYROXINE, PSYLLIUM HUSK, PREDNISONE, MONTELUKAST SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, DICLOFENAC SODIUM, ZOLPIDEM TARTRATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, |
||||
| 945 | 24959243 |
US |
50 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 946 | 24959431 |
HN |
82 | 2 |
Cerebrovascular accident, Blood glucose increased, Mental disorder, Mobility decreased, Condition aggravated, Decreased appetite, |
||||
INSULIN GLARGINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 947 | 24960343 |
US |
75 | 1 |
Extrasystoles, Blood glucose increased, Asthenia, Hyperphagia, Illness, |
||||
INSULIN GLARGINE, |
||||
| 948 | 24960431 |
US |
1 | |
Cardiogenic shock, Hyperthyroidism, Blood glucose increased, Vomiting, |
||||
SEMAGLUTIDE, |
||||
| 949 | 24960439 |
IN |
62 | 2 |
Gastrointestinal oedema, Retinal degeneration, Blood glucose increased, Weight fluctuation, Flatulence, Abdominal distension, Hyperchlorhydria, Dyspepsia, Pain, Movement disorder, Fear of disease, Tension, Vomiting, Nausea, Anxiety, Stress, Depression, Asthenia, Fatigue, Hunger, Abdominal pain upper, Peripheral swelling, Gait disturbance, Dyspnoea exertional, Pain in extremity, Frequent bowel movements, Eructation, Insomnia, Headache, Gastrointestinal sounds abnormal, Limb discomfort, Sleep disorder, Binge eating, Back pain, Irritability, Anger, Pruritus, Rash, Diarrhoea, Visual impairment, |
||||
LORLATINIB, LORLATINIB, |
||||
| 950 | 24960527 |
US |
67 | 2 |
Ludwig angina, Acute respiratory failure, Streptococcal infection, Sepsis, Pneumonia, Bradycardia, Drug ineffective, Blood glucose increased, Inappropriate schedule of product administration, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 951 | 24960528 |
US |
53 | 2 |
Blindness, Neuropathy peripheral, Hypertension, Blood glucose increased, Gas gangrene, Bed bug infestation, Gait disturbance, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 952 | 24960542 |
US |
86 | 2 |
Cholelithiasis, Blood glucose increased, Blood calcium increased, Blood urea increased, Blood sodium decreased, Lacrimation increased, Blood potassium decreased, Urinary tract infection, Injection site haemorrhage, Injection site pain, Peripheral swelling, Blood glucose decreased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 953 | 24961013 |
US |
63 | |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 954 | 24961467 |
PL |
30 | 2 |
Ill-defined disorder, Hepatotoxicity, Blood glucose increased, Thyroxine free increased, Blood glucose increased, Blood glucose increased, Blood glucose decreased, Catheter site infection, |
||||
PACLITAXEL, PEMBROLIZUMAB, CARBOPLATIN, DOXORUBICIN HYDROCHLORIDE, |
||||
| 955 | 24961956 |
US |
57 | 2 |
Blood glucose increased, Glycosylated haemoglobin increased, Weight increased, |
||||
DULAGLUTIDE, TIRZEPATIDE, SEMAGLUTIDE, |
||||
| 956 | 24961979 |
US |
17 | 2 |
Pancreatitis, Blood glucose increased, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, DORNASE ALFA, |
||||
| 957 | 24962133 |
US |
68 | 1 |
Visual impairment, Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, GLIPIZIDE, |
||||
| 958 | 24962566 |
US |
2 | |
Blood glucose increased, |
||||
EVOLOCUMAB, |
||||
| 959 | 24952865 |
CN |
2 | |
Thyroid disorder, Blood glucose increased, Off label use, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, REPAGLINIDE, ACARBOSE, ACARBOSE, |
||||
| 960 | 24953082 |
US |
83 | 1 |
Infusion site reaction, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO-AABC, INSULIN LISPRO-AABC, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 961 | 24953103 |
US |
2 | |
Dizziness, Gait disturbance, Fall, Dysstasia, Blood glucose increased, Mobility decreased, Fatigue, |
||||
OMAVELOXOLONE, OMAVELOXOLONE, OMAVELOXOLONE, |
||||
| 962 | 24953662 |
US |
||
Blood glucose increased, Fatigue, Arthralgia, |
||||
OSILODROSTAT, AMLODIPINE BESYLATE, LEVETIRACETAM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TIRZEPATIDE, INSULIN ASPART, INSULIN GLARGINE, |
||||
| 963 | 24953705 |
US |
77 | 2 |
Blood glucose increased, Drug dose omission by device, Device issue, Wrong technique in device usage process, |
||||
INSULIN GLARGINE, |
||||
| 964 | 24954218 |
US |
||
Blood glucose increased, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 965 | 24954377 |
US |
2 | |
Illness, Influenza, Drug ineffective, Blood glucose increased, Food craving, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 966 | 24954431 |
US |
66 | 2 |
Thyroid disorder, Psoriatic arthropathy, Blood glucose increased, Nausea, Injection site bruising, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 967 | 24954439 |
US |
34 | |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 968 | 24954446 |
US |
61 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 969 | 24954451 |
US |
66 | 1 |
Expired product administered, Blood glucose increased, Dizziness, Accidental underdose, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN ASPART, |
||||
| 970 | 24954598 |
US |
55 | 2 |
Extra dose administered, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 971 | 24954716 |
US |
2 | |
Injection site pain, Blood glucose increased, Device mechanical issue, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 972 | 24955211 |
US |
2 | |
Blood glucose increased, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, |
||||
| 973 | 24955329 |
US |
||
Fluid retention, Blood glucose increased, |
||||
ECULIZUMAB, |
||||
| 974 | 24955982 |
US |
||
Blood glucose increased, |
||||
| 975 | 24956064 |
DE |
||
Blood glucose increased, |
||||
| 976 | 24956326 |
US |
||
Diabetes mellitus, Inflammation, Blood glucose increased, |
||||
EVOLOCUMAB, |
||||
| 977 | 24956380 |
US |
57 | 2 |
Incorrect product administration duration, Blood glucose increased, Visual impairment, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 978 | 24956692 |
US |
71 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 979 | 24956759 |
US |
62 | 2 |
Blood glucose increased, |
||||
PALBOCICLIB, |
||||
| 980 | 24956972 |
US |
61 | 1 |
Staphylococcal infection, Blood glucose increased, Weight increased, Glycosylated haemoglobin increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, PIOGLITAZONE, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 981 | 24957098 |
US |
29 | 1 |
Presyncope, Vomiting, Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 982 | 24957214 |
US |
59 | 2 |
Drug ineffective, Glycosylated haemoglobin increased, Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 983 | 24957263 |
US |
62 | |
Drug ineffective, Blood glucose increased, |
||||
DULAGLUTIDE, INSULIN DEGLUDEC, |
||||
| 984 | 24946302 |
US |
67 | 2 |
Glycosylated haemoglobin increased, Weight decreased, Blood glucose increased, |
||||
| 985 | 24946346 |
BR |
2 | |
Diabetes mellitus inadequate control, Blood glucose increased, Glycosylated haemoglobin increased, Off label use, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 986 | 24946392 |
US |
61 | 1 |
Lung disorder, Blood glucose increased, Nausea, |
||||
SEMAGLUTIDE, |
||||
| 987 | 24946634 |
US |
63 | 1 |
Blood glucose increased, Device malfunction, Nasal congestion, Abdominal discomfort, Diarrhoea, Stress, |
||||
INSULIN ASPART, INSULIN GLARGINE, |
||||
| 988 | 24946637 |
AZ |
67 | 1 |
Gangrene, Blood glucose increased, Incorrect dose administered, |
||||
INSULIN DEGLUDEC, |
||||
| 989 | 24946638 |
BR |
828 | 2 |
Blood glucose increased, Device issue, Device leakage, Device failure, Wrong technique in product usage process, |
||||
INSULIN ASPART INJECTION, INSULIN ASPART, INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 990 | 24946671 |
US |
1 | |
Fall, Blood glucose increased, |
||||
ADALIMUMAB, |
||||
| 991 | 24946887 |
DE |
46 | 1 |
COVID-19, Suicidal ideation, Asthenia, Gait disturbance, Off label use, Myalgia, Muscle tightness, Electric shock sensation, Musculoskeletal pain, Dysstasia, Sciatica, Arthralgia, Erectile dysfunction, Dry mouth, Insomnia, Fine motor skill dysfunction, Paraesthesia, Blood pressure increased, Heart rate increased, Abdominal pain, Emotional distress, Hypokinesia, Depression, Hypertension, Nightmare, Night sweats, Acne, Myalgia, Dyspnoea, Peroneal nerve palsy, Drug ineffective, Fall, Blood glucose increased, Tremor, |
||||
OCRELIZUMAB, TIZANIDINE, DALFAMPRIDINE, |
||||
| 992 | 24946890 |
US |
50 | 1 |
Therapeutic response decreased, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 993 | 24947053 |
US |
2 | |
Blood glucose increased, Tremor, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 994 | 24947397 |
US |
70 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 995 | 24947481 |
US |
73 | 1 |
Blood glucose increased, |
||||
NIVOLUMAB, IPILIMUMAB, CARBOPLATIN, PEMBROLIZUMAB, |
||||
| 996 | 24947689 |
US |
66 | 1 |
Blood glucose increased, Back disorder, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 997 | 24947691 |
US |
52 | |
Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 998 | 24947693 |
US |
52 | 1 |
Incorrect dose administered, Blood glucose increased, Injection site warmth, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 999 | 24948186 |
US |
66 | 1 |
Staphylococcal infection, Somnolence, Depression, Tremor, Blood glucose increased, |
||||
DEUTETRABENAZINE, |
||||
| 1000 | 24948579 |
US |
75 | 2 |
Cataract, Blood glucose increased, Product dose omission issue, Wrong technique in device usage process, Device mechanical issue, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28